Science Explorer Interactive view Map
Company · Basaluzzo · Italy

Iris Vernici (Italy)

Research works
55
▼ 77% vs 2013–17
Citations
4.8k
87.3 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
25%
world 28%

Not ranked overall: Iris Vernici (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Iris Vernici (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Inflammation, Antibiotic Resistance, Vaccine, Prevention, Gastric Cancer and Helicobacter pylori.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology14▲ 6.3×21 topics
  2. Pathogenesis12▲ 38×6 topics
  3. Inflammation11▲ 8.3×6 topics
  4. Antibiotic Resistance8▲ 34×5 topics
  5. Vaccine7▲ 32×7 topics
  6. Prevention6▲ 30×2 topics
  7. Gastric Cancer6▲ 92×1 topic
  8. Helicobacter pylori6▲ 234×1 topic
  9. Immunity6▲ 31×3 topics
  10. Antimicrobial Resistance5▲ 38×4 topics
  11. Autoimmunity4▲ 40×3 topics
  12. Bacterial Meningitis4▲ 268×1 topic
  13. Neisseria meningitidis4▲ 268×1 topic
  14. Zoonotic Transmission4▲ 69×2 topics
  15. Cancer4▲ 5.0×4 topics
  16. Clinical Practice Guidelines4▲ 12×2 topics
  17. Angiogenesis3▲ 15×3 topics
  18. Immune Regulation3▲ 47×2 topics
  19. Antigen Presentation3▲ 59×2 topics
  20. Heart Failure3▲ 13×2 topics
  21. Galectins3▲ 268×1 topic
  22. Macrophage Activation3▲ 268×1 topic
  23. Pathogenicity3▲ 55×2 topics
  24. Vaccine Development3▲ 16×3 topics
  25. Brachyspira3▲ 427×1 topic
  26. Genomic Analysis3▲ 17×2 topics
  27. Proliferative Enteropathy3▲ 427×1 topic
  28. Immune Response3▲ 7.7×5 topics
  29. Virulence3▲ 65×2 topics
  30. Escherichia coli2▲ 203×1 topic
  31. Shiga toxin2▲ 203×1 topic
  32. Cancer Therapy2▲ 6.5×3 topics
  33. Community-Acquired Pneumonia2▲ 96×1 topic
  34. Pneumococcal Conjugate Vaccine2▲ 96×1 topic
  35. COVID-19 Vaccine2▲ 92×1 topic
  36. Vaccine Hesitancy2▲ 104×1 topic
  37. Epitope Prediction2▲ 187×1 topic
  38. Peptide-MHC Binding2▲ 187×1 topic
  39. Immunotoxin2▲ 106×1 topic
  40. Ricin Poisoning2▲ 106×1 topic

Which research topics does Iris Vernici (Italy) publish most on?

By volume in 2022–2025: Ophthalmology and Visual Impairment Studies, Corneal surgery and disorders, Intraocular Surgery and Lenses and Metabolism and Genetic Disorders.

  1. 1 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
  2. 2 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Intraocular Surgery and Lenses Ophthalmology 0 works
  4. 4 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
  5. 5 ATP Synthase and ATPases Research Molecular Biology 0 works
  6. 6 Mitochondrial Function and Pathology Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.0%not open75.0%

World: 28% of research is openly available.

with international co-authors31.5%domestic only68.5%

World: 19% is written across borders.

How has Iris Vernici (Italy)'s research output changed?

Output in 2018–2022 was 77% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.